Canada Markets open in 6 hrs 53 mins

Intellia Therapeutics, Inc. (NTLA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
46.94-1.39 (-2.88%)
At close: 04:00PM EDT
49.00 +2.06 (+4.39%)
After hours: 06:30PM EDT
Sign in to post a message.
  • M
    MickTheAwesome
    Intellia and Caribou are extremely lucky liquidity is not at issue. Both are sitting on a massive bundle of cash which during these see uncertain times is a valuable asset in its own right.
  • S
    Sam
    Once Intellia gets their first drug approval, people will be regretting they never bought at these levels.
  • P
    Peter
    Excellent call. Excellent company. Just need to be patient.
  • B
    Brian
    Long term investors know these companies will cure diseases one day. A bad market happens.
  • S
    Sweet
    be honest, I don't understand why institutions are beating down R&D related good companies. Most of these companies have enough cash for two years and they don't need to borrow. Plus they don't have PE to justify. The only do or die was that whether they are able to meet milestone delivery or whether they are able to get FDA approval once they complete phase 3.
  • B
    Brian
    If you do not believe Crispr will work, then sell or short. If you believe and just think it is a bad market, be patient. I remember when REGN was a 6 dollar stock. I scientifically see where Cripsr can change everything.
  • A
    Ariel
    Started a position @47 and change, gtla. See you in 2028
  • B
    Brian
    Analyst are scared to lower the price on Crispr stocks. They know any discovery will blow these stocks up and destroy any shorts. At some point institutions will have no choice but to put money to work in this sector. It has been in bear territory forever.
  • C
    Charles
    I am still here and long on my holdings, but had to take a short break to have a two-vessel CABG done, successfully. Doing home health rehab now and soon cardiac rehab. Other than that I am doing fine. Best. of luck to all.
  • A
    Anthony
    Call your broker and get off margin and request your shares not to be borrowed this is the only way your shares can’t be used against you period end of story
  • F
    Frank
    When is data due here again?
  • S
    Shortburner
    You can not hold stock in this market---earnings may drop this another 10 bucks!!!
  • F
    Ferit
    so without US patent, what will the valuation be, 11B instead of 15B? no need to drop.
  • H
    Hal
    they never let it get into the $12s they had it at $13.00 years ago hope they go bankrupt at thi point
  • F
    Frank
    Not worried ine bit adding the whole way down
  • F
    Frank
    When is our next set of data due here?
  • A
    Ariel
    initated a postion @ 43.15 glta
  • C
    Charles
    We have seen unprecedented innovation in biotech in the last 5 years (more than any other prior period). But we need to build real (and disciplined) businesses, not just spew out new platforms. Quality companies will come out even stronger! #innovationthatmatters

    Sam Kulkarni
  • L
    Lethargic
    Easy money, 100 shares every dollar under 60 and heavy on 2023/2024 call options. Work in the field, wouldn’t lean on editas but Intellia has a lot of big pharmas lining up to further develop the pipeline. Shorts will always be greedy and speak without any knowledge of the sector. Let them
  • B
    Brian
    Come on Fed. Lets get inflation under control. This should help the rotation back to innovation. We all know the market is always trying to guess the future. Money never stays stagnant. Nibble at these gene editing companies, for life and health. We know they can change the program to cure disease. They are just trying to make it safe. Please support.